Effect of competitive tactics on performance: the case of the pharmaceutical industry

  1. Castillo-Apraiz, Julen 1
  2. Matey, Jesus 1
  1. 1 Universidad del País Vasco/Euskal Herriko Unibertsitatea
    info

    Universidad del País Vasco/Euskal Herriko Unibertsitatea

    Lejona, España

    ROR https://ror.org/000xsnr85

Actas:
Proceedings of the 2nd International Symposium on Partial Least Squares Path Modeling: The conference for PLS Users

Editorial: University of Twente

ISBN: 9789036540568

Año de publicación: 2015

Tipo: Aportación congreso

DOI: 10.3990/2.333 GOOGLE SCHOLAR lock_openAcceso abierto editor

Resumen

Competitive tactics play a key role in explaining different levels of organizational performance since they are the linkers between strategy formulation and implementation. This study focuses on two main competitive tactics, namely, Quality-Oriented Competitive Tactic (Quality) and Cost-Oriented Competitive Tactic (Cost), which are the ones that are closely related to Porter’s generic competitive strategies. Apart from that, we will analyze two other important competitive tactics, namely, Innovation-Oriented Competitive Tactic (Innovation) and Marketing-Oriented Competitive Tactic (Marketing) which will mediate the relationship between the main tactics and performance. Hence, we try to adopt an integrative posture by viewing competitive tactics in the pharmaceutical industry as inextricably linked, forming the fundamental pillars on which sustainable competitive advantage could be established.